Page last updated: 2024-11-02

pantoprazole and Hepatitis

pantoprazole has been researched along with Hepatitis in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Hepatitis: INFLAMMATION of the LIVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kataria, A1
Stolow, E1
Hubbard, H1

Other Studies

1 other study available for pantoprazole and Hepatitis

ArticleYear
Pantoprazole-induced acute hepatocellular and cholestatic hepatitis.
    Postgraduate medical journal, 2022, Volume: 98, Issue:1155

    Topics: Carcinoma, Hepatocellular; Hepatitis; Humans; Liver Neoplasms; Pantoprazole

2022